- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07842094
Effect of LiFE-SePBT on Postural Stability in Community-dwelling Older Adults: an Assessor-blinded Randomised Controlled Trial (LiFE-SePBT)
Combined Effects of Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Training on Postural Stability in Community-dwelling Older Adults: an Assessor-blinded Randomised Controlled Trial
This study is an assessor-blinded randomised controlled trial investigating the effects of combined Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Training (LiFE-SePBT) on postural stability in community-dwelling older adults with an elevated risk of falling.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Participants will be randomly assigned to two groups: LiFE-SePBT or an attention control group. All participants will provide their written informed consent before baseline assessment. The study will be reported and conducted in line with the CONSORT statement. Participants will be recruited via convenience sampling in the local community. After baseline assessment, both groups will receive five 90-minute intervention sessions over 10 weeks. Between-group differences in behaviour will be examined before and after training to identify immediate training-induced changes in postural stability. Retention of the changes in postural stability will be assessed four months after the training period. Fall incidents will be followed up for 12 months after training.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Bryan Tsz Lok Heung, Bsc
- Numéro de téléphone: +852-9210-2491
- E-mail: 26119566r@connect.poly.hk
Lieux d'étude
-
-
Kowloon
-
Hung Hom, Kowloon, Hong Kong, 000
- Recrutement
- The Hong Kong Polytechnic University
-
Contact:
- Bryan Tsz Lok Heung, Bsc
- Numéro de téléphone: +852-9210-2491
- E-mail: 26119566r@connect.polyu.hk
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Community-dwelling older adults aged 60 or older
- Able to communicate effectively in Cantonese or Mandarin
- Able to walk independently on level ground for at least 30 minutes
- A score of ≥ 6 in the Abbreviated Mental Test (Hong Kong)
- Have fallen in the preceding year, have concerns about falling, or feel unsteady while walking or standing
Exclusion Criteria:
- Uncorrected vision or hearing impairment
- Osteoporosis
- Hip or knee replacement within the last year
- Resting blood pressure ≥ 160/100 mmHg even with medication taken
- A score of ≤ 6 in 5-items Geriatric Depression Scale (GDS-5)
- Have musculoskeletal, cardiovascular, mental, or neurological disorders that preclude their participation in the assessment or intervention safety
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: LiFE-SePBT
5 sessions of combined Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Training (LiFE-SePBT) will be delivered. The LiFE component involves having participants embed functional exercises into their lifestyle, as well as practising recovering their balance upon self-initiated perturbation. Each session is 90 minutes long and will be hosted once every 2 weeks. |
Lifestyle-integrated Functional Exercise and Self-initiated Perturbation-based Balance Exercise (LiFE-SePBT) is a synergistic fall prevention programme. LiFE programme targets generic balance and muscle strength whereas SePBT mainly influences through reactive balance. |
|
Comparateur placebo: Attention control group
Participants in the attention control group will receive 5 sessions of upper limb mobilisation and flexibility exercises. Each session is 90 minutes long and will be held once every 2 weeks. |
Upper limb mobilisation and flexibility training, including arm circles, deltoid stretches, shoulder internal rotations, etc. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Generic Balance ability
Délai: Week 0 (baseline assessment), week 10 (post-assessment), week 22 (i.e., 3-month follow-up assessment)
|
Generic balance ability will be assessed by the Mini-BESTest. Mini-BESTest can challenge balance across anticipatory postural adjustments, postural responses, sensory orientation and stability in gait, allowing for a comprehensive examination of improvements that occur in reactive control. |
Week 0 (baseline assessment), week 10 (post-assessment), week 22 (i.e., 3-month follow-up assessment)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of real-life falls
Délai: 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months after the intervention.
|
The number of real-life falls in months after randomization will be recorded. Fall circumstances and related injuries will be required via phone contact. A fall is defined as an event resulting in a person unintentionally coming to rest on the ground or other lower level, not as the result of a major intrinsic event (e.g., syncope, stroke, or overwhelming hazard such as an earthquake). |
1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, and 12 months after the intervention.
|
|
Dynamic balance
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Dynamic balance will be assessed by Alternative Step Test (in the unit of seconds). |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Balance confidence
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Balance confidence will be measured with the Chinese version of the shortened version of Activities-specific Balance Confidence Scale (ABC-6). The scale value is from 0 to 100, with higher values representing higher balance confidence. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Functional lower body strength
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Functional lower body strength will be assessed by Five-time Sit to Stand Test (in the unit of seconds). |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Number of laboratory falls
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Participants will be exposed to one trip-like perturbation and slip-like perturbation on each foot at an unexpected time. The number of falls upon perturbations will be recorded. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Depressive symptoms
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Depressive symptoms will be assessed by Five-Item Geriatric Depression Scale. Participants will be asked to answer 5 questions as yes or no. The answer "no" for the first question and "yes" for the other four questions will be evaluated for depression. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Health-related quality of life
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Health-related quality of life will be assessed by the EQ-5D-5L. In the EQ-5D-5L descriptive system, each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. Each health state is identified by a five-digit code, with 11111 representing the best and 55555 the worst possible health state. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Muscle activations
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Muscle activations will be assessed by surface electromyography using an electromyography system (Trigno IM, Delsys Inc., Natick, MA, USA). Fourteen electrodes are placed bilaterally over erector spinae, rectus abdominis, gastrocnemius medialis, biceps femoris, rectus femoris, tibialis anterior, and gluteus medius according to the SENIAM guidelines (www.seniam.org) by the physical therapist. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Physical activity
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Physical activity will be assessed by the Physical Activity Scale for the Elderly. This questionnaire will ask participants to recall their activity over the last 7-days. Activity types include sitting, walking, sport/recreation, exercise, occupational and household. A total score for physical activity can be calculated using these answers and the predetermined weights associated with each activity. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Cognitive flexibility and executive function
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Cognitive flexibility and executive function will be assessed by Trial Making Tests A and B (in the unit of seconds). |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Perceived ability to execute reactive stepping
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
The perceived ability to execute reactive stepping in different scenarios in real life situations via Short-Form Balance Recovery Confidence (SF-BRC) Scale. Each item is ranked from 0-10. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
|
Exercise adherence
Délai: Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Exercise adherence will be measured via the Chinese version of Exercise Adherence Rating Scale (EARS-C). The total score of this scale is ranked between 0 to 24; each item is graded from 0 to 4 while item 1, 4 and 6 are reverse-scored. |
Week 0, baseline assessment; Week 10, post-intervention assessment; Week 22, follow-up assessment.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Charlotte Sau Lan Tsang, PhD, The Hong Kong Polytechnic University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- HSEARS20260330008
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Due to participant privacy concerns.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .